By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The European Molecular Biology Laboratory has launched an online compound database of information on the properties of over 500,000 drug and drug-like small molecules and their targets, including genomic and chemical data, for use in drug discovery research.

Hosted by EMBL's European Bioinformatics Institute, the ChemBLdb holds genomic and chemical data that can be used to help determine whether a particular molecule has the correct sequences to make an effective drug.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.